Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

Abstract Background Cardiovascular complications are common in kidney transplant patients and calcification propensity of blood, measured as T50, is associated with cardiovascular outcomes. Paricalcitol supplementation affects calcium/phosphate homeostasis and may affect calcification propensity. To...

Full description

Bibliographic Details
Main Authors: Amin Ussif, Hege Pihlstrøm, Andreas Pasch, Hallvard Holdaas, Anders Hartmann, Knut Smerud, Anders Åsberg
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Nephrology
Subjects:
Paricalcitol
Calcification propensity score
Randomized controlled trial
Renal transplantation
Online Access:http://link.springer.com/article/10.1186/s12882-018-1000-8

Similar Items

Similar Items